BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He W, Chen M, Li C, Wang X, Chen W, Pan L, Cui Y, Yu Z, Wu G, Yang Y, Tang Q, Wang J, He Z. Metformin decreases Cyp26a1 to prevent hepatocarcinogenesis through down- regulating CD8+ T cells.. [DOI: 10.1101/2022.04.27.489721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Abd El-fattah EE, Zakaria AY. Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach. International Immunopharmacology 2022;109:108889. [DOI: 10.1016/j.intimp.2022.108889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]